Clinical reference Biomarker Directory
Back to directory

VWF

Established

VWF is central to diagnosing von Willebrand disease, the most common inherited bleeding disorder, via a standardized 2021 algorithm.

Also known as VWF von Willebrand factor
In plain language

VWF helps platelets stick together to stop bleeding and also carries another clotting factor around in the blood. When it's low or not working properly, it causes the most common inherited bleeding disorder. Treatment differs importantly by subtype — a common bleeding medication actually makes one specific subtype worse rather than better.

Biomarker & context

Von Willebrand factor (VWF) is a large multimeric glycoprotein that mediates platelet adhesion at sites of vessel injury and carries factor VIII in circulation; its deficiency or dysfunction causes von Willebrand disease (VWD), the most common inherited bleeding disorder.

What it indicates

Reduced VWF antigen or activity supports VWD diagnosis; the disease is classified into type 1 (partial quantitative deficiency), type 2 (qualitative functional defects, with four subtypes), and type 3 (near-complete absence, causing severe bleeding similar to hemophilia).

Diagnosis & clinical testing

The 2021 ASH/ISTH/NHF/WFH diagnostic guidelines standardized how VWD is diagnosed, using VWF antigen and activity levels together with a defined algorithm; a key nuance is the activity-to-antigen ratio (commonly using a 0.7 cutoff, though guidelines vary from 0.5-0.7) to identify type 2 (qualitative defect) VWD, which needs different management than type 1 or type 3.

Guiding treatment

Treatment depends on VWD type and bleeding severity: desmopressin (DDAVP) works well for many type 1 patients by triggering release of stored VWF, while type 2B and type 3 patients generally require VWF/factor VIII concentrate instead, since desmopressin can worsen type 2B disease by releasing dysfunctional VWF.

Clinical significance

Treatment differs critically by VWD subtype; desmopressin can worsen type 2B disease rather than help it.

References
  1. ASH. (2021). ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Advances.
  2. PubMed. (2023). Von Willebrand factor testing ratios in the diagnosis and subtyping of von Willebrand disease.